Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma.

HCC NASH epigenetic changes genetic factors obesity therapeutics

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
20 May 2020
Historique:
received: 30 04 2020
revised: 14 05 2020
accepted: 17 05 2020
entrez: 24 5 2020
pubmed: 24 5 2020
medline: 24 5 2020
Statut: epublish

Résumé

Obesity is a global, intractable issue, altering inflammatory and stress response pathways, and promoting tissue adiposity and tumorigenesis. Visceral fat accumulation is correlated with primary tumor recurrence, poor prognosis and chemotherapeutic resistance. Accumulating evidence highlights a close association between obesity and an increased incidence of hepatocellular carcinoma (HCC). Obesity drives HCC, and obesity-associated tumorigenesis develops via nonalcoholic fatty liver (NAFL), progressing to nonalcoholic steatohepatitis (NASH) and ultimately to HCC. The better molecular elucidation and proteogenomic characterization of obesity-associated HCC might eventually open up potential therapeutic avenues. The mechanisms relating obesity and HCC are correlated with adipose tissue remodeling, alteration in the gut microbiome, genetic factors, ER stress, oxidative stress and epigenetic changes. During obesity-related hepatocarcinogenesis, adipokine secretion is dysregulated and the nuclear factor erythroid 2 related factor 1 (Nrf-1), nuclear factor kappa B (NF-κB), mammalian target of rapamycin (mTOR), phosphatidylinositol-3-kinase (PI3K)/phosphatase and tensin homolog (PTEN)/Akt, and Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathways are activated. This review captures the present trends allied with the molecular mechanisms involved in obesity-associated hepatic tumorigenesis, showcasing next generation molecular therapeutic strategies and their mechanisms for the successful treatment of HCC.

Identifiants

pubmed: 32443737
pii: cancers12051290
doi: 10.3390/cancers12051290
pmc: PMC7281233
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R01 CA230561
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA244993
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA240004
Pays : United States
Organisme : NIDDK NIH HHS
ID : 1R01DK107451-01A1
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107451
Pays : United States
Organisme : NCI NIH HHS
ID : 1R01CA230561-01A1, 1R01CA240004-01 and 1R01CA244993-01
Pays : United States
Organisme : U.S. Department of Defense
ID : CA170048

Références

Science. 2013 Jan 11;339(6116):218-22
pubmed: 23223452
Cell Metab. 2009 Apr;9(4):327-38
pubmed: 19356714
Nature. 2012 Feb 01;482(7384):179-85
pubmed: 22297845
JCI Insight. 2020 Mar 12;5(5):
pubmed: 32161197
Hepatology. 2020 Mar 10;:
pubmed: 32154934
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Lancet Oncol. 2019 Feb;20(2):282-296
pubmed: 30665869
Cancer. 2003 Apr 15;97(8):1929-40
pubmed: 12673720
J Clin Invest. 2012 Aug;122(8):2884-97
pubmed: 22820290
J Hepatol. 2016 Jan;64(1):203-14
pubmed: 26341826
Gut. 2014 Jan;63(1):170-8
pubmed: 23348961
Hepatology. 2009 Aug;50(2):462-71
pubmed: 19444874
Cancer Res. 2019 Jul 15;79(14):3676-3688
pubmed: 31097476
Mol Cell. 2017 Aug 3;67(3):400-410.e7
pubmed: 28735896
Mol Cell. 2013 Sep 12;51(5):618-31
pubmed: 24011591
Cell. 2012 Jul 6;150(1):12-27
pubmed: 22770212
J Biol Chem. 2002 Jul 12;277(28):25226-32
pubmed: 11994296
Nat Chem Biol. 2018 Dec;14(12):1118-1126
pubmed: 30374165
Nature. 2017 Nov 16;551(7680):340-345
pubmed: 29144460
J Hepatol. 2017 May;66(5):1037-1046
pubmed: 28167322
J Biol Chem. 2011 Oct 21;286(42):36258-67
pubmed: 21878621
Mol Metab. 2014 May 20;3(5):565-80
pubmed: 25061561
Gastroenterology. 2020 Jun;158(8):2250-2265.e20
pubmed: 32060001
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
Mol Cancer. 2018 May 15;17(1):90
pubmed: 29764424
Cancer Res. 2011 Dec 15;71(24):7608-16
pubmed: 22009537
Front Immunol. 2019 Jun 04;10:1255
pubmed: 31214196
Cell. 2009 Mar 20;136(6):1056-72
pubmed: 19303849
Lancet. 2017 Jun 24;389(10088):2492-2502
pubmed: 28434648
Adolesc Med State Art Rev. 2017 Fall;28(2):379-405
pubmed: 30416642
Hepatology. 2017 Jun;65(6):1875-1890
pubmed: 28073161
Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):411-428
pubmed: 31028350
Hepatology. 2014 Jan;59(1):228-41
pubmed: 23857252
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Hepatology. 2015 Jan;61(1):108-18
pubmed: 24917523
Hepatology. 2013 Apr;57(4):1458-68
pubmed: 23175471
JAMA. 2014 Feb 26;311(8):806-14
pubmed: 24570244
Clin Liver Dis. 2012 Aug;16(3):567-85
pubmed: 22824481
Nat Rev Genet. 2017 Dec;18(12):731-748
pubmed: 28989171
Sci Rep. 2019 Aug 12;9(1):11585
pubmed: 31406127
Hepatology. 2017 Aug;66(2):466-480
pubmed: 28437865
FASEB J. 2002 Aug;16(10):1292-4
pubmed: 12060674
Nat Cell Biol. 2011 Feb;13(2):132-41
pubmed: 21258367
Lancet. 2018 Mar 31;391(10127):1301-1314
pubmed: 29307467
N Engl J Med. 2018 Mar 22;378(12):1096-1106
pubmed: 29562163
Cell Metab. 2019 Aug 6;30(2):385-401.e9
pubmed: 31390551
Cell Rep. 2017 Mar 28;18(13):3043-3051
pubmed: 28355557
Gastroenterology. 2008 Jan;134(1):268-80
pubmed: 18166358
J Hepatol. 2014 Jul;61(1):75-81
pubmed: 24607626
J Clin Invest. 2012 Aug;122(8):2871-83
pubmed: 22820288
Bioconjug Chem. 2015 Aug 19;26(8):1651-61
pubmed: 26079152
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):264-9
pubmed: 20018759
Nat Genet. 2012 May 06;44(6):694-8
pubmed: 22561517
Gastroenterology. 2020 May;158(7):1999-2014.e1
pubmed: 32044314
Nat Rev Cancer. 2017 Sep 25;17(10):620-632
pubmed: 28943640
Front Med (Lausanne). 2015 Jun 04;2:36
pubmed: 26131450
Curr Opin Gastroenterol. 2017 May;33(3):128-133
pubmed: 28257306
Clin Gastroenterol Hepatol. 2009 Oct;7(10):1104-12
pubmed: 19523535
Gastroenterology. 2007 Jan;132(1):330-42
pubmed: 17241883
J Hepatol. 2009 Feb;50(2):351-7
pubmed: 19070395
Gut. 2016 Nov;65(11):1850-1860
pubmed: 26282675
Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5
pubmed: 25865049
Sci Rep. 2016 Mar 03;6:22640
pubmed: 26935028
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9793-8
pubmed: 18599449
Hepatology. 2017 Oct;66(4):1111-1124
pubmed: 28520213
Nat Med. 2012 Jun;18(6):934-42
pubmed: 22561686
Gastroenterol Hepatol (N Y). 2017 Dec;13(12):751-753
pubmed: 29339953
Hepatol Commun. 2018 Apr 16;2(6):654-665
pubmed: 29881817
Mol Metab. 2020 Apr;34:27-42
pubmed: 32180558
Metabolism. 2017 Jun;71:17-32
pubmed: 28521870
Clin Cancer Res. 2009 Aug 15;15(16):5073-81
pubmed: 19671867
N Engl J Med. 2018 Jul 05;379(1):54-63
pubmed: 29972759
Cancer Cell. 2014 Oct 13;26(4):549-64
pubmed: 25314080
Cancer Cell. 2016 Jul 11;30(1):161-175
pubmed: 27411590
JAMA. 2015 Jun 9;313(22):2263-73
pubmed: 26057287
Cell. 2005 Jul 1;121(7):977-90
pubmed: 15989949
Cell Metab. 2011 Jan 5;13(1):11-22
pubmed: 21195345
Hepatology. 2011 Dec;54(6):1975-86
pubmed: 21837751
Clin Cancer Res. 2018 Feb 1;24(3):547-559
pubmed: 29070526
Liver Int. 2016 Mar;36(3):317-24
pubmed: 26601627
J Lipid Res. 2009 Oct;50(10):2111-6
pubmed: 19738004
Hepatology. 2009 Apr;49(4):1176-84
pubmed: 19072831
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8913-8
pubmed: 24927523
Genes Dev. 2011 Apr 15;25(8):795-800
pubmed: 21498569
Am J Clin Nutr. 2009 Dec;90(6):1453-6
pubmed: 19828708
Oncogene. 2008 Sep 25;27(43):5651-61
pubmed: 18521080
J Biol Chem. 2000 Mar 24;275(12):9047-54
pubmed: 10722755
Hepatology. 2015 Feb;61(2):431-3
pubmed: 25271144
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Gastroenterology. 2013 Feb;144(2):323-32
pubmed: 23063971
Cell. 2000 Sep 15;102(6):731-44
pubmed: 11030617
Cancer Discov. 2017 May;7(5):522-538
pubmed: 28202625
Nature. 2009 Apr 30;458(7242):1131-5
pubmed: 19339967
IUBMB Life. 2019 Dec;71(12):1952-1961
pubmed: 31408278
Hepatology. 2011 Jul;54(1):133-44
pubmed: 21488066
Mol Ther. 2012 Feb;20(2):339-46
pubmed: 22146341
Hepatology. 2008 Apr;47(4):1191-9
pubmed: 18318442
Hepatology. 2008 Feb;47(2):455-60
pubmed: 18038452
J Hepatol. 2016 Aug;65(2):305-13
pubmed: 27132171
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Genes Cells. 2011 Feb;16(2):123-40
pubmed: 21251164
PLoS One. 2014 Apr 24;9(4):e96185
pubmed: 24763545
FASEB J. 2017 Sep;31(9):3999-4010
pubmed: 28536120
Cancer Causes Control. 2001 Jan;12(1):13-21
pubmed: 11227921
Cancer Prev Res (Phila). 2012 Apr;5(4):544-52
pubmed: 22467080
J Gastrointest Surg. 2019 Jan;23(1):101-111
pubmed: 30367397
Cell Metab. 2009 Nov;10(5):405-18
pubmed: 19883618
Transl Oncol. 2019 Aug;12(8):1092-1107
pubmed: 31176993
Gastroenterology. 2007 Aug;133(2):647-58
pubmed: 17681183
World J Gastroenterol. 2019 Jun 28;25(24):2977-2989
pubmed: 31293335
Clin Cancer Res. 2015 Feb 15;21(4):925-33
pubmed: 25480831
Cancer Cell. 2007 Feb;11(2):119-32
pubmed: 17292824
Clin Gastroenterol Hepatol. 2015 Jul;13(7):1337-1345.e6
pubmed: 25478922
Cell. 2019 Nov 14;179(5):1033-1055
pubmed: 31730848
Hepatology. 2010 Oct;52(4):1322-33
pubmed: 20803560
Nat Rev Gastroenterol Hepatol. 2018 Mar;15(3):137-151
pubmed: 29317776
Front Genet. 2019 May 29;10:486
pubmed: 31191608
Int J Obes (Lond). 2008 Sep;32 Suppl 4:S7-12
pubmed: 18719601
Nat Genet. 2014 Apr;46(4):352-6
pubmed: 24531328
Gastroenterology. 2013 Nov;145(5):1076-87
pubmed: 23916847
J Hepatol. 2015 Aug;63(2):408-19
pubmed: 25817558
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Hepatology. 2015 Sep;62(3):751-61
pubmed: 25753988
Gut. 2009 Sep;58(9):1281-8
pubmed: 19074179
Liver Int. 2019 Apr;39(4):714-726
pubmed: 30663219
Hepatology. 2005 Nov;42(5):987-1000
pubmed: 16250043
Cancer Res. 2017 Mar 1;77(5):1155-1167
pubmed: 27993818
J Gastroenterol. 2013 Nov;48(11):1249-58
pubmed: 23329365
Nature. 2016 Mar 10;531(7593):253-7
pubmed: 26934227
Cell. 2010 Jan 22;140(2):197-208
pubmed: 20141834
EBioMedicine. 2018 Apr;30:14-28
pubmed: 29526577
Nat Genet. 2003 Mar;33 Suppl:245-54
pubmed: 12610534
Gastroenterology. 2017 May;152(6):1449-1461.e7
pubmed: 28132890
Cancer Cell. 2017 Jun 12;31(6):771-789.e6
pubmed: 28609656
Cancer Res. 2007 Jul 1;67(13):6092-9
pubmed: 17616664
J Hepatol. 2014 Jan;60(1):110-7
pubmed: 23978719
Cancer Res. 2015 Nov 15;75(22):4803-16
pubmed: 26383163
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9521-9526
pubmed: 31019090
J Clin Invest. 2006 Jul;116(7):1793-801
pubmed: 16823477
Nat Genet. 2008 Dec;40(12):1461-5
pubmed: 18820647
Physiol Rev. 2012 Oct;92(4):1515-42
pubmed: 23073625
Hepatology. 2017 May;65(5):1526-1542
pubmed: 28027591
J Hepatol. 2013 Jul;59(1):138-43
pubmed: 23485520
Aliment Pharmacol Ther. 2013 Jul;38(2):134-43
pubmed: 23718573
Nat Commun. 2018 Dec 14;9(1):5321
pubmed: 30552326
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
J Hepatol. 2000 Dec;33(6):907-14
pubmed: 11131452
Am J Physiol Endocrinol Metab. 2013 Oct 15;305(8):E987-98
pubmed: 23964070
Gut. 2017 Mar;66(3):429-437
pubmed: 26740296
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15324-9
pubmed: 21876127
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90
pubmed: 24042449
Oncotarget. 2016 Jan 19;7(3):2646-59
pubmed: 26544731
J Hepatol. 2011 Dec;55(6):1400-8
pubmed: 21703185
Hepatology. 2012 Jun;55(6):2005-23
pubmed: 22488764
J Hepatol. 2016 Sep;65(3):579-88
pubmed: 27261415
Nat Commun. 2010 Apr 12;1:3
pubmed: 20975665
Prog Mol Biol Transl Sci. 2016;140:151-84
pubmed: 27288829
J Clin Invest. 2004 Jun;113(12):1774-83
pubmed: 15199412
EBioMedicine. 2018 Nov;37:307-321
pubmed: 30316865
Cancer Res. 2015 Mar 1;75(5):846-57
pubmed: 25592151
Nat Rev Cancer. 2013 Nov;13(11):800-12
pubmed: 24132111
Hepatology. 2019 Jan;69(1):107-120
pubmed: 29665135
Gastroenterology. 2005 Jun;128(7):1898-906
pubmed: 15940625
Gastroenterology. 2002 Sep;123(3):745-50
pubmed: 12198701
Cancer Cell. 2012 Apr 17;21(4):504-16
pubmed: 22516259
Cell Metab. 2010 Sep 8;12(3):224-36
pubmed: 20816089
J Hepatol. 2020 Feb;72(2):230-238
pubmed: 31954488
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65
pubmed: 24080776
J Transl Med. 2020 Mar 13;18(1):126
pubmed: 32169080
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Gastroenterology. 2007 May;132(6):2169-80
pubmed: 17498510
N Engl J Med. 2003 Apr 24;348(17):1625-38
pubmed: 12711737
Int J Biol Sci. 2017 Jul 6;13(7):852-867
pubmed: 28808418
J Lipid Res. 2015 Mar;56(3):722-36
pubmed: 25598080
J Clin Invest. 2020 Jun 1;130(6):2992-3004
pubmed: 32365055
Hepatology. 2010 Dec;52(6):2096-108
pubmed: 20890892
Hepatology. 2013 Feb;57(2):601-9
pubmed: 23055155
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
Am J Prev Med. 2012 Jun;42(6):563-70
pubmed: 22608371
Cancer Res. 2007 Feb 1;67(3):863-7
pubmed: 17283114
Hepatology. 2019 Oct 19;:
pubmed: 31630428
Cancer Cell. 2014 Dec 8;26(6):826-839
pubmed: 25453901
Hepatology. 2013 Sep;58(3):1054-64
pubmed: 23526469
Science. 2007 Apr 13;316(5822):285-8
pubmed: 17431181
Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):220-226
pubmed: 29748147
Oncotarget. 2017 Aug 1;8(51):88517-88528
pubmed: 29179453
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Hepatology. 2020 Mar 19;:
pubmed: 32190914
BMC Cancer. 2019 Nov 21;19(1):1128
pubmed: 31752753
Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103
pubmed: 15508109
Curr Opin Oncol. 2014 Jan;26(1):100-7
pubmed: 24275855
Lancet. 2015 Mar 14;385(9972):956-65
pubmed: 25468160
Nat Genet. 2009 Jan;41(1):18-24
pubmed: 19079260
Lancet Oncol. 2018 May;19(5):682-693
pubmed: 29625879
Gastroenterology. 2012 Sep;143(3):787-798.e13
pubmed: 22687285
Nat Rev Mol Cell Biol. 2005 Nov;6(11):838-49
pubmed: 16261189
Hepatology. 2010 Sep;52(3):1134-42
pubmed: 20648554
Hepatology. 2016 Mar;63(3):764-75
pubmed: 26600078
Gut. 2013 Apr;62(4):606-15
pubmed: 22773548
J Hepatol. 2015 Jun;62(6):1296-303
pubmed: 25623824

Auteurs

Yetirajam Rajesh (Y)

Department of Human and Molecular Genetics, Massey Cancer Center, VCU Institute of Molecular Medicine (VIMM), Virginia Commonwealth University, Richmond, VA 23298, USA.

Devanand Sarkar (D)

Department of Human and Molecular Genetics, Massey Cancer Center, VCU Institute of Molecular Medicine (VIMM), Virginia Commonwealth University, Richmond, VA 23298, USA.

Classifications MeSH